This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction. Defining Remission in Patients Treated With Antidepressants

Michael E. Thase, MD

Published: August 1, 1999

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Achieving complete remission, or a state of "wellness," should now be considered the standard of care in the pharmacotherapy of depression, anxiety, and comorbid depression with anxiety. Since these are complex syndromes, especially when complicated by comorbidities, effective measurement of remission is difficult.

In the mid-1950s and 1960s, there was much skepticism regarding the use of drugs to treat psychiatric disorders, and psychoanalytic therapies predominated theambulatory care of depressed people.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...